Zoetis to showcase new monoclonal antibody therapies at London Vet Show 2026
The stand will also demonstrate Zoetis’ wider approach to supporting clinical decision-making, including dermatology treatments Apoquel®, Cytopoint®, and Apoquel® Chewable and tools to strengthen communication with pet owners. Zoetis Diagnostics' comprehensive, cutting-edge portfolio of point-of-care analysers and rapid tests are also at the stand, delivering deeply informed medical insights to support fast, confident treatment decisions. Visitors will have the opportunity to sign up to hear more about the new Vetscan OmniMax chemistry analyser coming soon, and explore the full range of solutions including the Vetscan Hub, Vetscan Vue+, Vetscan Imagyst, Vetscan VS2, and Vetscan OptiCell – each designed to elevate patient care through meaningful innovation.
“As the world’s
leading animal health company, we are proud to bring
veterinary professionals innovation and industry-leading insights at London Vet
Show this year, both on stand and in the Zoetis Learning Academy Theatre,” said
Tim Burgess, Interim General Manager, Zoetis UK. “The challenges clinicians
face are changing, from chronic disease in ageing pets to the pressure on
practices to make timely decisions. Our role is to apply science to those
problems, develop solutions that are clinically meaningful, and make sure they
fit the realities of everyday veterinary care. Our offering at London Vet Show
demonstrates our strong foundation in science and purpose, and our commitment
to innovation, customer partnership, and industry advancement.”
Zoetis
Learning Academy
The Zoetis Learning
Academy Theatre will bring the latest developments in veterinary science and
innovation directly to the show floor. Across two days, expert speakers will
explore advances in monoclonal antibody science, osteoarthritis, disease
detection, haematology, dermatology and chronic disease care, translating
emerging evidence into practical insight for clinicians.
The programme reflects
the company’s focus on unmet needs that become more pressing as animals live
longer. Sessions on renal disease will explore earlier detection and disease
progression, alongside innovations in animal health including monoclonal
antibody research, approaches to osteoarthritis and updates in haematological
medicine. Lectures on dermatology delve deeper into the compliance and care
giver burden, and the role of the veterinary nurse in chronic disease care.
The Zoetis Learning
Academy programme for Thursday, November 19, and Friday, November 20, is as
follows:
|
Thursday |
Session |
Speaker |
|
10:00-10:50 |
The
Biologics Revolution: Navigating the Past, Present, and Future of Monoclonal
Antibodies in Veterinary Medicine |
Richard
Goldstein, Global Chief Medical Officer & Head of Medical Affairs, Zoetis |
|
11:00-11:50 |
Catching
the Quiet Decline: A Practical Approach to Renal Disease Detection |
Adam
Gow, Zoetis Global Clinical Consultation Lead and Zoetis Global Clinical
Consultation Service, Zoetis |
|
12:00-12:50 |
Canine
Chronic Kidney Disease – Rethinking the Approach |
Rosanne
Jepson, Professor of Small Animal Internal Medicine and Nephrology, Royal
Veterinary College |
|
13:00-13:50 |
Recent
evidence in disease progression in canine chronic kidney disease |
Myles
McKenna, Global Director of Veterinary Operations: Internal Medicine, Zoetis |
|
14:00-14:50 |
The
Haematology Toolbox Upgrade: Investigating Anaemia Without the Algebra |
Mellora
Sharman, Zoetis Global Clinical Consultation Service - Internal Medicine
Consultant, Zoetis |
|
15:00-15:50 |
RUMA
CA&E - Managing the most common clinical conditions presented while
practising good antibiotic stewardship in the consult room. |
Steve
Howard, RUMA CA&E Chair, Chief Veterinary Advisor at PDSA, RUMA |
|
Friday |
Session |
Speaker |
|
9:00-9:50 |
Chronic
Disease Care: The essential role of the Veterinary Nurse |
Jennifer
Grant, Head Nurse, Dermatology Referral Service |
|
10:00-10:50 |
Compliance
and Caregiver Burden: The impacts of therapy choice |
Jill Maddison,
Professor of General Practice - Royal Veterinary College Zoe
Belshaw, Veterinary Consultant Researcher - EviVet |
|
11:00-11:50 |
Librela
- A Clinical Update |
Ruth
Moxon, National Veterinary Manager Pain, Zoetis |
|
12:00-12:50 |
Introducing
Lenivia |
Richard
Goldstein, Global Chief Medical Officer & Head of Medical Affairs, Zoetis |
|
13:00-13:50 |
Introducing
Portela |
Richard
Goldstein, Global Chief Medical Officer & Head of Medical Affairs, Zoetis |
Find Zoetis at London
Vet Show stand Q50 or the Zoetis Learning Academy Theatre. For more information
please visit: London
Vet Show 2026 | Zoetis
About Zoetis
Zoetis is the world’s leading animal
health company, driven by a singular purpose: to nurture our world and
humankind by advancing care for animals. With a legacy of nearly 75 years,
Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal
illness, supporting veterinarians, livestock producers, and pet owners in over
100 countries. We integrate deep scientific expertise, data-driven R&D,
advanced manufacturing, and commercial excellence to deliver meaningful
innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and
digital solutions. Guided by our vision to be the most trusted and valued
animal health company, Zoetis is committed to setting new standards for the
future of animal care through innovation, customer obsession, and
purpose-driven colleagues. To learn more, visit Zoetis.com.
Media Contact:
Kurtis L'Estrange, kurtis.lestrange@zoetis.com
MM-52880, November 2026